Abstract: To determine plasma concentrations of angiopoietin (Ang)-1, Ang-2, Tie-2, and vascular endothelial growth factor (VEGF) in patients with sepsis-induced multiple organ dysfunction syndrome (MODS) and determine their association with mortality.
INTRODUCTION
E merging evidences disclose that endothelial activation and injury are involved in the development of multiple organ dysfunction syndrome (MODS) during sepsis. In addition to its function as vascular barrier, endothelial cells are implicated in inflammatory responses and coagulation imbalance in sepsis. 1 A study showed that endothelial injury is an independent predictor for MODS and mortality in patients with severe sepsis. The degree of endothelial injury correlates with the numbers of organ failure in those patients. 2 Taken together, sepsis-induced endothelial injury plays a critical role in mediating illness progression and outcome.
The angiopoietin (Ang) family contains 3 members in humans, including Ang-1, Ang-2, and Ang-4.
3,4 Both Ang-1 and Ang-2 bind to the same site of Tie2 receptor with similar affinity. 5 After binding to Tie-2 receptor, Ang-1 causes activation of Tie-2. In contrast, Ang-2 exerts antagonistic response to Tie-2. 6 Ang-1 inhibits the endothelial response to inflammatory cytokines and exerts protective effects. In addition, Ang-1 inhibits vascular endothelial growth factor (VEGF)-induced bloodvessel formation and adhesion molecule expression, and attenuates increased VEGF and thrombin-induced permeability. 7, 8 However, Ang-2 triggers inflammatory responses by activating the endothelial cell and increasing permeability. 9, 10 Because of the important role of Angs in endothelial activation and vascular barrier breakdown, many studies have explored their role as biomarkers of sepsis. [11] [12] [13] Evidence has consistently shown increased Ang-2 levels in patients with sepsis compared with those without. But discrepancy exists in the levels of Ang-1 in patients with sepsis. Previous reports demonstrate that circulating Ang-1 levels remain unchanged, or even decrease, in septic patients. [11] [12] [13] Although decreased Ang-1 levels have recently been reported as an independent predictor for mortality in pediatric patients with severe bacterial infection, 13 few comprehensive clinical investigations have examined the role of circulating Ang-1 during the clinical course from MODS to subsequent mortality in sepsis. Whether longitudinally measured Ang-1 levels correlate with the resolution or aggravation of MODS during sepsis remains unclear.
The study aimed to measure plasma concentrations of Ang-1, Ang-2, Tie-2, and VEGF in patients with sepsis-induced organ failure and examine the independent association between these markers and mortality. These markers were also serially measured to determine their correlation with evolutional change of MODS status during the course of severe sepsis.
MATERIALS AND METHODS

Patients
This study was conducted from October 2008 to April 2010 in a 37-bed medical intensive care unit (MICU) of Chang Gung Memorial Hospital, a tertiary medical center. Ninety-six patients (46 males and 50 females) were recruited within 24 hours of diagnosis of severe sepsis. Sepsis was defined as the presence of infection and at least 2 of the following criteria.
14 of the American College of Chest Physicians/Society of Critical Medicine Consensus Committee: temperature >388C or <368C, heart rate >90 beats/minute, respiratory rate >20 breaths/minute, PaCO 2 < 32 mmHg, white blood cell >12,000/mm 3 or <4000/mm 3 or >10% immature (band) forms. Patients' baseline data included age, vital signs, blood gas analysis, organ failure count, and hematologic and biochemical tests. Acute Physiology and Chronic Health Evaluation II (APACHE II) scores and Sequential Organ Failure Assessment (SOFA) score 15 were used to assess illness severity. Underlying medical history was also collected, including diabetes mellitus, hypertension, neurologic disease, congestive heart failure, malignancy, and chronic airway obstruction disease.
The hospital's Institutional Review Board approved the study and all patients or their legal representatives provided written informed consent. The patients were treated according to the Surviving Sepsis Guidelines. 16 
Definitions
Organ failure was diagnosed according to the ACCP-SCCM Consensus Committee criteria.
14 Respiratory failure was defined as needing mechanical ventilation. Cardiovascular failure was defined as systolic BP 90 mmHg or mean arterial pressure 60 mmHg for 1 hour, despite fluid bolus. Renal failure was defined as low urine output (eg, <0.5 mL/kg/hour), increased creatinine (!50% increase from baseline), or the need for acute dialysis. Hematologic failure was defined as low platelet count (<100,000/mm 3 ) or PT/PTT > upper limits of normal. Metabolic failure was low pH with high lactate (eg, pH < 7.30 and plasma lactate > upper limits of normal), while hepatic failure was liver enzyme levels >2Â the upper limits of normal. CNS failure was defined as altered consciousness or reduced Glasgow Coma Score. Those with more than 2 organ dysfunctions were defined as MODS.
2,14 Day 1 was the day the patients were recruited. The number of organ failure was determined on days 1, 3, and 7 of sepsis in each patient. Patients with persistently MODS on days 1 and 7 were defined as having persistent MODS. The no MODS group was defined as having organ failure counts less than 3 on days 1 and 7. Patients with MODS on day 1 but with organ failure number less than 3 on day 7 were defined as resolved MODS.
Blood Sampling and Measurement
Blood samples were taken on days 1, 3, and 7 of sepsis for plasma collection. The maximum levels of laboratory data were used for determination of organ function and comparison between survivors and nonsurvivors. Soluble Ang-1, Ang-2, VEGF, and Tie-2 plasma concentrations (Sekisui Diagnostics, MA) on days 1, 3, and 7 were determined by ELISA based on the manufacturer's instructions. Plasma levels of these mediators were compared between patients with and without MODS, and between survivors and nonsurvivors. For sequential MODS changes, patients were classified into 3 groups (ie, no MODS, resolved MODS, and persistent MODS) and compared.
Statistical Analysis
All data were expressed as mean AE SEM or percentage. Since most continuous variables were skewed, nonparametric approaches were used. Quantitative variables between 2 groups were compared using the Mann-Whitney test for continuous and ordinal variables, and the chi-square test for nominal variables. Nonparametric tests (Wilcoxon signed rank) were used for comparison of time points within a group. Differences among comparison for more than 2 groups were determined using the Kruskal-Wallis test. The primary outcome studied was in-hospital mortality.
Univariate analyses were primarily used for the selection of variables, based on P value less than 0.1. Selected variables, including APACHE II score, SOFA score, Ang-1 levels, Ang-2 levels, C-reactive protein (CRP), and lactate were entered into a Cox proportional hazards model to identify the net effects of each individual factor. Hazard ratios (HR) with 95% confidence interval (CI) were used to assess independent contributions of significant factors. Receiver operating characteristic (ROC) curves for day 1 APACHE II scores, plasma levels of Ang-1, Ang-2, CRP, and lactate for predicting the development of MODS and mortality during ICU stay were plotted, and the respective areas under the curves were calculated. A P < 0.05 was considered statistically significant. All analysis was done using the SPSS software version 10.0 (Chicago, IL).
RESULTS
Baseline Characteristics
The 96 patients enrolled were classified as survivors and nonsurvivors during their hospital stay. Their baseline characteristics were listed in (Table 1) . Thirty-six (37.5%) died during their hospitalization. There were no differences between survivors and nonsurvivors in age, sex, shock, bacteremia, and origin of sepsis. However, the nonsurvivors had higher illness severity than survivors, as indicated by APACHE II score (21.7 AE 1.2 vs 17.4 AE 0.8, P ¼ 0.002). The SOFA scores of nonsurvivors differed from those of survivors on day 1 (8.2 AE 0.6 vs 5.9 AE 0.3, P < 0.0001). They also had higher levels of lactate (24.4 AE 2.5 vs 17.4 AE 1.7 mg/dL, P ¼ 0.025) and Ang-2 (15.8 AE 3.3 vs 9.5 AE 1.2 ng/mL, P ¼ 0.035) but lower Ang-1 levels (4.0 AE 0.5 vs 7.1 AE 0.5 ng/mL, P < 0.0001) than survivors.
Cox Proportional Hazard Analysis for Predicting Mortality
The APACHE II and SOFA scores and CRP, lactate, and Ang-1 levels less than the median value (<5.5 ng/mL) and Ang-2 level higher than the media value (>7.0 ng/mL) were subjected to Cox proportional hazard analysis (Table 2) . Except for Ang-1 level (HR, 2.57; 95% CI 1.12-5.90, P ¼ 0.025), all other variables did not remain significant in the Cox proportional hazard analysis. Therefore, Ang-1 levels less than the median value were the only independent predictor for mortality in patients with severe sepsis.
Plasma Levels of Angiopoietins and Clinical Outcomes
The plasma levels of Ang-1 were lower in nonsurvivors than in survivors on days 1 (4.0 AE 0.5 vs 7.1 AE 0.5 ng/mL, P < 0.0001), 3 (3.8 AE 0.6 vs 7.1 AE 0.5 ng/mL, P < 0.0001), and 7 (4.7 AE 0.7 vs 11.0 AE 0.8 ng/mL, P < 0.0001) ( Figure 1A ). In contrast, plasma Ang-2 levels were higher in nonsurvivors than in survivors only on day 1 (15.8 AE 2.0 vs 9.5 AE 1.2 ng/mL, P ¼ 0.035) but not on day 3 (12.7 AE 1.9 vs 10.8 AE 1.7 ng/mL, P ¼ 0.474) and day 7 (10.7 AE 1.7 vs 7.2 AE 1.0 ng/mL, P ¼ 0.060) ( Figure 1B) .
Similarly, plasma Ang-1 levels were lower in MODS patients than in those without MODS on days 1 (4.0 AE 0.5 (Figure 2A ). However, plasma levels of Ang-2 were higher in MODS patients than in non-MODS patients on day 7 (15.4 AE 2.5 vs 7.0 AE 0.8 ng/mL, P < 0.0001) but not on day 1 (14.5 AE 2.3 vs 8.9 AE 1.6 ng/mL, P ¼ 0.053) and day 3 (13.0 AE 1.7 vs 10.6 AE 1.7 ng/mL, P ¼ 0.399) ( Figure 2B ).
Plasma Ang-1 concentrations in septic patients stratified by MODS status were compared (Figure 3 ). Plasma Ang-1 concentrations were lower in patients with persistent MODS (n ¼ 17) (3.0 AE 0.6 ng/mL on day 1 and 2.4 AE 0.5 ng/mL on day 7) than in patients with no MODS (n ¼ 29) (day 1, 8.1 AE 0.5 ng/ mL, P < 0.0001 and day 7, 11.0 AE 0.7 ng/mL, P < 0.0001). However, in patients with resolved MODS (n ¼ 43), the Ang-1 levels increased from day 1 to day 7 (4.7 AE 0.6 ng/mL vs 9.1 AE 1.4 ng/mL, P ¼ 0.004). Plasma Ang-1 levels in patients with resolving MODS were similar to those of patients with no MODS on day 7 (P ¼ 0.188). Patients with persistent MODS also had persistently low levels of Ang-1 on days 1 and 7 (P ¼ 0.482). In patients with no MODS, plasma Ang-1 level mildly increased from day 1 to day 7 (P ¼ 0.016). Plasma Ang-1 levels in patients with resolving MODS were similar to those of patients with persistent MODS on day 1 (P ¼ 0.07).
Area Under the ROC Curve for Day 1 Soluble Factor Levels, SOFA Score and APACHE II Scores in Predicting Outcomes
Areas under the ROC curve for plasma Ang-1, Ang-2, CRP, and lactate levels, and SOFA and APACHE II scores on (Table 3) . Values for areas under the ROC curves showed that day 1 plasma Ang-1 levels had good discriminative power in predicting MODS (0.743) and mortality (0.898). In addition, APACHE II score also had good discriminative power for MODS (0.674) and mortality (0.740). The areas under the ROC curve for day 1 plasma Ang-2 (0.717), CRP (0.617), and lactate (0.716) levels and SOFA scores (0.883) were adequate only in predicting mortality but not MODS.
Plasma Ang-1 and Organ Dysfunction and Illness Severity
To further understand the relationship between Ang-1 and organ dysfunction, Ang-1 levels were compared to several variables of illness severity and laboratory findings associated with organ dysfunction (Table 4) . Ang-1 negatively correlated with APACHE II (r ¼ À0.255, P ¼ 0.012) and SOFA scores (r ¼ À0.565, P < 0.0001), number of organs affected by failure (r ¼ À0.580, P < 0.0001), and serum CRP (r ¼ À0.241, P ¼ 0.018) and lactate (r ¼ À0.206, P ¼ 0.044) levels. In contrast, the plasma Ang-1 levels positively correlated with platelet count (r ¼ 0.780, P < 0.0001) such that the platelet count of patients with plasma Ang-1 higher than the median level (n ¼ 48) (259.6 AE 16.5 1000/mm 3 ) was higher than those with Ang-1 level lower than the median value (n ¼ 48) (106.4 AE 11.4 1000/mm 3 , P < 0.0001) (Figure 4) .
DISCUSSION
This study reveals that plasma Ang-1 levels changes and are decreased with the evolution of MODS in patients with severe sepsis. Concentrations of Ang-1 increase in patients with resolved MODS but remain low in patients with persistent MODS. Moreover, Ang-1 levels on day 1 of sepsis ÃP < 0.05 compared to day 1 no MODS group; # P < 0.05 compared to day 7 no MODS group; f independently predict mortality during hospital stay. Analysis of area under the ROC curve confirms that day 1 plasma Ang-1 levels have good discriminative power for predicting MODS and mortality, and decreased Ang-1 levels are associated with decreased platelet count in patients with severe sepsis.
In the current study, the APACHE II and SOFA scores, and CRP, lactate, Ang-1, and Ang-2 levels are different between survivors and nonsurvivors, even though Ang-1 level is the only independent predictor for mortality after Cox proportional analysis. The functions of Ang-1 are to maintain vessel integrity, inhibit vascular leakage, suppress inflammatory gene expression, and prevent recruitment and transmigration of leukocytes. 17 The inadequate amount of Ang-1 in septic patients contributes to uncontrolled inflammation, injury of endothelial cells, and increased vascular permeability. 17 In fact, endothelial injury 2 and increased vascular permeability 18, 19 have been documented as possible mechanisms underlying sepsis-induced organ failure and mortality. The failure to maintain quiescence status of endothelial cells due to inadequate Ang-1 during sepsis may play an important role in the development of organ failure and followed by mortality. Consistent with previous studies, this study demonstrates that day 1 plasma Ang-1 and Ang-2 levels are significantly different between nonsurvivors and survivors among patients with severe sepsis. Only Ang-1 level remains significant after multivariate analysis. 11, 13 Nonetheless, other studies have not consistently shown a correlation between Ang-1 levels and mortality. A previous study showed that plasma Ang-1 levels were similar between surgical patients with acute respiratory distress syndrome (ARDS) and those without. 20 Similarly, another study also failed to demonstrate a difference in plasma Ang-1 levels between survivors and nonsurvivors among mechanically ventilated patients with septic shock.
11 Discrepancies in the observed association between low Ang-1 levels and MODS and mortality in severe sepsis in the present study and in previous ones may relate to the difference in study populations and illness severity. In contrast to previous studies recruiting surgical patients complicated with ARDS or mechanically ventilated patients with septic shock, the present study recruited patients with sepsis complicated by organ dysfunction in an MICU. Less than 30% of the patients had septic shock in this study.
This study also demonstrates that persistently depressed plasma Ang-1 level is associated with MODS and subsequent death in patients with severe sepsis. The present study reveals that Ang-1 levels are repressed in patients with MODS and increase with MODS resolution. The values for areas under the ROC curve also show that plasma Ang-1 level on day 1 of sepsis has good discriminative power for predicting both MODS and mortality outcomes. These findings suggest that plasma Ang-1 level may serve as an early predictor of survival in septic patients. By serial measurement of Ang-1 levels, the persistent depressed Ang-1 levels may be used to identify the patients with persistent MODS and are vulnerable to mortality. In contrast, increased plasma Ang-1 on day 7 may indicate patients with resolved MODS. Our study results, if further confirmed by large-scale prospective studies, provided a useful marker to stratify the patients by measuring plasma Ang-1 levels. Therefore, serial measuring plasma Ang-1 in patients with severe sepsis should prompt efforts to identify and treat the modifiable factors associated with mortality. In patients with persistently decreased Ang-1 levels, some interventions may be instituted to improve survival. According to the Surviving Sepsis Guidelines, 16 those interventions include: further studies performed promptly for confirming potential source of infection, reassessment of antibiotic therapy with microbiology and clinical data, a low tidal volume and limitation of inspiratory plateau pressure strategy for acute lung injury (ALI)/ARDS, and maintain tissue perfusion by targeting a hemoglobin of 7 to 9 g/dL. However, further studies are warranted to confirm the application of plasma Ang-1 monitoring on the management of patients with severe sepsis.
Plasma Ang-1 levels negatively correlated well with organ failure status indicated by SOFA score and organ failure counts (Table 4) . These findings further support the theory that inadequate amount of Ang-1 has a pathogenic role in sepsis and contributes to organ dysfunction, likely through endothelial activation and subsequent vascular leak, which could result in circulatory, hepatic, and renal compromise. These results are in agreement with previous clinical study reporting that plasma levels of Ang-1 are associated with organ failure in sepsis. 21 Indeed, an animal study had disclosed that administration of Ang-1 significantly protects against sepsis-associated organ dysfunctions and improves survival time, most likely by preserving endothelial barrier function. 22 Recently, platelets have been identified as carriers of angiogenic factors since a high amount of Ang-1 is found in platelets. 23, 24 Results here demonstrate a positive correlation between Ang-1 level and platelet count. Moreover, the platelet counts of patients with plasma Ang-1 >median level is higher than those with Ang-1 level <median value. These findings suggest that sepsis-induced thrombocytopenia may contribute to the depressed levels of Ang-1 in patients with severe sepsis. Thrombocytopenia is typically a result of sepsis and mainly caused by sepsis-induced disseminated intravascular coagulation (DIC). 2 The presence of DIC is closely linked to sepsis-induced MODS and higher mortality rates. 25, 26 The thrombocytopenia-associated depressed Ang-1 levels may play a certain role in the progression from sepsis-induced DIC to MODS and subsequent death.
Our study has limitations. First, we stratified the survivors versus nonsurvivors according to the in-hospital mortality. It is possible that patients who initially recovered from the septic insult may have died from another complication of critical illness. This would have an effect to decrease the power of Ang-1 to predict mortality in those patients with cause of death other than sepsis. However, our results that persistently decreased Ang-1 correlated with MODS course and mortality in patients with severe sepsis reinforces the use of Ang-1 as a predictive biomarker. Second, our study was performed in a single center. A larger study at multiple sites should be performed to confirm these findings.
In conclusion, plasma Ang-1 levels are repressed in sepsisinduced MODS and mortality. Plasma concentrations of this marker increase concomitantly with the resolution of MODS and independently predict mortality in patients with severe sepsis. These may suggest that the inadequate amount of Ang-1 plays a critical role in progression from MODS to mortality. Thus, plasma Ang-1 levels may be used for monitoring MODS status in patients with severe sepsis, particularly day 1 plasma Ang-1 levels, which may be used as an early predictor of mortality.
